Telemedicine has become an invaluable tool in cancer care, especially in the context of the COVID-19 pandemic. It allows for remote consultations, follow-ups, and even some forms of therapy administration. Telemedicine platforms enable patients to access specialist care without the need for travel, which is particularly beneficial for those living in remote areas. Furthermore, virtual tumor boards, where multidisciplinary teams can discuss cases remotely, have become more prevalent, ensuring that patients receive comprehensive and coordinated care.
